These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31402621)

  • 21. Sexually Divergent Mortality and Partial Phenotypic Rescue After Gene Therapy in a Mouse Model of Dravet Syndrome.
    Niibori Y; Lee SJ; Minassian BA; Hampson DR
    Hum Gene Ther; 2020 Mar; 31(5-6):339-351. PubMed ID: 31830809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
    Yamagata T; Raveau M; Kobayashi K; Miyamoto H; Tatsukawa T; Ogiwara I; Itohara S; Hensch TK; Yamakawa K
    Neurobiol Dis; 2020 Jul; 141():104954. PubMed ID: 32445790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synthetic neuroactive steroid SGE-516 reduces seizure burden and improves survival in a Dravet syndrome mouse model.
    Hawkins NA; Lewis M; Hammond RS; Doherty JJ; Kearney JA
    Sci Rep; 2017 Nov; 7(1):15327. PubMed ID: 29127345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetics and clinical correlation of Dravet syndrome and its mimics - experience of a tertiary center in Taiwan.
    Liu YH; Cheng YT; Tsai MH; Chou IJ; Hung PC; Hsieh MY; Wang YS; Chen YJ; Kuo CY; Lin JJ; Wang HS; Lin KL
    Pediatr Neonatol; 2021 Sep; 62(5):550-558. PubMed ID: 34226156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy.
    Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A
    Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome.
    Anderson LL; Bahceci DA; Hawkins NA; Everett-Morgan D; Banister SD; Kearney JA; Arnold JC
    PLoS One; 2023; 18(1):e0280842. PubMed ID: 36701411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?
    Lim BC; Hwang H; Kim H; Chae JH; Choi J; Kim KJ; Hwang YS; Yum MS; Ko TS
    Epilepsy Res; 2015 Jan; 109():34-9. PubMed ID: 25524840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dravet syndrome and its mimics: Beyond SCN1A.
    Steel D; Symonds JD; Zuberi SM; Brunklaus A
    Epilepsia; 2017 Nov; 58(11):1807-1816. PubMed ID: 28880996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical myelinogenesis and reduced axon caliber in the Scn1a variant model of Dravet syndrome: An electron microscopy pilot study of the developing and mature mouse corpus callosum.
    Richards K; Jancovski N; Hanssen E; Connelly A; Petrou S
    Brain Res; 2021 Jan; 1751():147157. PubMed ID: 33069731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel rat model of Dravet syndrome recapitulates clinical hallmarks.
    Li M; Yang L; Qian W; Ray S; Lu Z; Liu T; Zou YY; Naumann RK; Wang H
    Neurobiol Dis; 2023 Aug; 184():106193. PubMed ID: 37295561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dravet syndrome: a genetic epileptic disorder.
    Akiyama M; Kobayashi K; Ohtsuka Y
    Acta Med Okayama; 2012; 66(5):369-76. PubMed ID: 23093055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-Selective Adeno-Associated Virus-Mediated
    Tanenhaus A; Stowe T; Young A; McLaughlin J; Aeran R; Lin IW; Li J; Hosur R; Chen M; Leedy J; Chou T; Pillay S; Vila MC; Kearney JA; Moorhead M; Belle A; Tagliatela S
    Hum Gene Ther; 2022 Jun; 33(11-12):579-597. PubMed ID: 35435735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dravet syndrome: the main issues.
    Guerrini R
    Eur J Paediatr Neurol; 2012 Sep; 16 Suppl 1():S1-4. PubMed ID: 22705271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies.
    Mei D; Cetica V; Marini C; Guerrini R
    Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo SCN1A pathogenic variants in the GEFS+ spectrum: Not always a familial syndrome.
    Myers KA; Burgess R; Afawi Z; Damiano JA; Berkovic SF; Hildebrand MS; Scheffer IE
    Epilepsia; 2017 Feb; 58(2):e26-e30. PubMed ID: 28084635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and Characteristics of Vaccination Triggered Seizures in Dravet Syndrome in Hong Kong: A Retrospective Study.
    Wong PT; Wong VC
    Pediatr Neurol; 2016 May; 58():41-7. PubMed ID: 26995069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hippocampal deletion of Na
    Stein RE; Kaplan JS; Li J; Catterall WA
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16571-16576. PubMed ID: 31346088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and comorbidities of SCN1A-related seizure disorders.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Sinoo C; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsy Behav; 2019 Jan; 90():252-259. PubMed ID: 30527252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case studies in neuroscience: a novel amino acid duplication in the NH
    Angus M; Peters CH; Poburko D; Brimble E; Spelbrink EM; Ruben PC
    J Neurophysiol; 2019 Nov; 122(5):1975-1980. PubMed ID: 31533007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling in a mouse model of Dravet syndrome.
    Hawkins NA; Calhoun JD; Huffman AM; Kearney JA
    Exp Neurol; 2019 Jan; 311():247-256. PubMed ID: 30347190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.